News Headlines
- Premier Research & InSilicoTrials Leverage Silico Modeling, Simulation, & Optimize Regulatory Pathways For Rare Disease Therapies 3/13/2023
-
Greenphire Expands Agreement With Merck To Help Reduce Financial And Travel Barriers For Clinical Trial Participants Worldwide
3/13/2023
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced an expansion of its agreement with Merck, known as MSD outside the United States and Canada. This expanded agreement now includes the use of Greenphire’s ClinCard with rideshare integration for participants across Merck’s clinical development network.
- Greenphire’s ConneX Global Travel Solution Expands In-Country Support 3/2/2023
- West Expands Corning Collaboration And Launches First Product 2/8/2023
-
Kymanox Acquires EU Based Anteris Medical And Anteris Helvetia
2/7/2023
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence.
- Kayentis And ClinOne Join Forces To Improve Efficiency And Patient Experience In Clinical Trials 1/18/2023
- Premier Research And CENTOGENE Launch Strategic Partnership To Accelerate And De-Risk Rare Disease Clinical Development 1/12/2023
- Trialbee Announces Trialbee Honey™ Omnichannel, Real-Time Patient Recruitment Tracking For Multiple Recruitment Sources At CNS Summit 2022 12/14/2022
- Trialbee And Acclinate Partner To Enhance Equitable Clinical Trial Participation 12/14/2022
-
Kindeva And Meridian Combine: Create Leading Drug-Device Combination Product CDMO
12/13/2022
The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”.